SG145782A1 - Process for the purification of terbinafine - Google Patents

Process for the purification of terbinafine

Info

Publication number
SG145782A1
SG145782A1 SG200806418-0A SG2008064180A SG145782A1 SG 145782 A1 SG145782 A1 SG 145782A1 SG 2008064180 A SG2008064180 A SG 2008064180A SG 145782 A1 SG145782 A1 SG 145782A1
Authority
SG
Singapore
Prior art keywords
terbinafine
acid addition
addition salt
purification process
free base
Prior art date
Application number
SG200806418-0A
Other languages
English (en)
Inventor
Ulrich Beutler
Gerhard Penn
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28686596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG145782(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SG145782A1 publication Critical patent/SG145782A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82Purification; Separation; Stabilisation; Use of additives
    • C07C209/84Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SG200806418-0A 2003-08-29 2004-08-27 Process for the purification of terbinafine SG145782A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0320312.2A GB0320312D0 (en) 2003-08-29 2003-08-29 Purification process

Publications (1)

Publication Number Publication Date
SG145782A1 true SG145782A1 (en) 2008-09-29

Family

ID=28686596

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200806418-0A SG145782A1 (en) 2003-08-29 2004-08-27 Process for the purification of terbinafine

Country Status (25)

Country Link
US (2) US20060076227A1 (fr)
EP (1) EP1694631A2 (fr)
JP (1) JP5208416B2 (fr)
KR (2) KR101233024B1 (fr)
CN (1) CN100491334C (fr)
AR (1) AR045506A1 (fr)
AU (1) AU2004268051B2 (fr)
BR (1) BRPI0413896A (fr)
CA (1) CA2536498C (fr)
EC (1) ECSP066382A (fr)
GB (1) GB0320312D0 (fr)
IL (1) IL173709A (fr)
IS (1) IS8369A (fr)
MA (1) MA28030A1 (fr)
MX (1) MXPA06002348A (fr)
MY (1) MY149357A (fr)
NO (1) NO20061404L (fr)
NZ (1) NZ545445A (fr)
PE (1) PE20050873A1 (fr)
RU (1) RU2367649C2 (fr)
SG (1) SG145782A1 (fr)
TN (1) TNSN06066A1 (fr)
TW (1) TWI350829B (fr)
WO (1) WO2005021483A2 (fr)
ZA (1) ZA200601264B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
EP1900378A1 (fr) * 2006-08-31 2008-03-19 Novartis AG Compositions pharmaceutiques pour le traitment d'infections fongiques
WO2010027468A1 (fr) 2008-09-05 2010-03-11 Travanti Pharma Inc. Conditionnement pour délivrance de médicaments ionophorétiques

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862103D1 (en) * 1977-08-19 1982-11-18 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
US5132459A (en) * 1979-08-22 1992-07-21 Sandoz Ltd. Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
DE3069633D1 (en) 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
CS232849B1 (cs) * 1983-05-04 1985-02-14 Ladislav Kalvoda Způsob přípravy honjugavaných eninů
RU2005717C1 (ru) * 1989-02-17 1994-01-15 Такеда кемикал-индастриз Лтд Способ получения производных аралкиламинов или их кислотно-аддитивных солей
CH678527A5 (en) 1989-06-22 1991-09-30 Sandoz Ag Trans(E)-N-(1-naphthyl:methyl)-heptenyl-amine prepn. - by simultaneously converting crude mixt. contg. cis and trans isomers to salt and precipitating trans isomer
JP3116364B2 (ja) 1989-10-02 2000-12-11 萬有製薬株式会社 エンイン誘導体の製造法
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU6360499A (en) 1999-10-22 2001-04-30 Richter Gedeon Vegyeszeti Gyar Rt. Process for preparing a substituted allylamine derivative and the salts thereof
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
ITMI20010421A1 (it) * 2001-03-01 2002-09-02 Ausimont Spa Membrane porose semipermeabili di fluoropolimeri semicristallini
ITMI20010430A1 (it) * 2001-03-02 2002-09-02 Dinamite Dipharma S P A In For Metodo per la sintesi di terbinafina
KR100459275B1 (ko) * 2001-12-28 2004-12-03 주식회사유한양행 터비나핀 또는 그의 염산염의 제조방법
ITMI20022534A1 (it) * 2002-11-29 2004-05-30 Dinamite Dipharma S P A Procedimento per la preparazione di terbinafina mediante l'uso di platino come catalizzatore.
US20060004230A1 (en) * 2004-06-30 2006-01-05 Joseph Kaspi Process for the preparation of terbinafine and salts thereof

Also Published As

Publication number Publication date
WO2005021483A2 (fr) 2005-03-10
IL173709A0 (en) 2006-07-05
CA2536498C (fr) 2012-10-09
KR101233024B1 (ko) 2013-02-13
WO2005021483A3 (fr) 2005-05-12
ZA200601264B (en) 2007-06-27
BRPI0413896A (pt) 2006-10-24
GB0320312D0 (en) 2003-10-01
US20090216047A1 (en) 2009-08-27
RU2006109640A (ru) 2007-10-10
US7985323B2 (en) 2011-07-26
CA2536498A1 (fr) 2005-03-10
RU2367649C2 (ru) 2009-09-20
CN1845895A (zh) 2006-10-11
JP5208416B2 (ja) 2013-06-12
CN100491334C (zh) 2009-05-27
US20060076227A1 (en) 2006-04-13
MXPA06002348A (es) 2006-05-22
EP1694631A2 (fr) 2006-08-30
MA28030A1 (fr) 2006-07-03
JP2007504110A (ja) 2007-03-01
TNSN06066A1 (en) 2007-10-03
KR20060119892A (ko) 2006-11-24
AU2004268051B2 (en) 2009-03-05
TWI350829B (en) 2011-10-21
NZ545445A (en) 2010-03-26
NO20061404L (no) 2006-08-25
KR20120054109A (ko) 2012-05-29
ECSP066382A (es) 2006-09-18
IS8369A (is) 2006-03-23
AU2004268051A1 (en) 2005-03-10
TW200523231A (en) 2005-07-16
IL173709A (en) 2012-02-29
MY149357A (en) 2013-08-30
AR045506A1 (es) 2005-11-02
PE20050873A1 (es) 2005-11-21

Similar Documents

Publication Publication Date Title
ES2170733A1 (es) Metodo para preparar citalopram purificado
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
WO2004045618A3 (fr) Nouveaux medicaments destines au traitement de la bronchopneumopathie chronique obstructive
TW200519075A (en) Novel compounds
DE502004004307D1 (de) Verfahren zur herstellung von gereinigten 1,3-substituierten imidazoliumsalzen
WO2005037798A3 (fr) Nouveaux composés
JO2493B1 (en) New phenyl azatidinone with improved physical properties and methods of preparation of drugs containing it and its uses
AU2002366726A1 (en) Process for the continuous quaternisation of tertiary amines with an alkyl halide
AU2003293042A8 (en) Process for purification of plasmid dna
SG145782A1 (en) Process for the purification of terbinafine
MX2007010403A (es) Proceso de purificacion.
WO2008102888A1 (fr) Nouveau pseudoglycolipide et son utilisation
EP1460065A4 (fr) Procedes pour produire des composes de diamine cyclique ou des sels de ceux-ci
DE60200535D1 (de) Verfahren zur Herstellung von hoch reinem Pemirolast
DE60233064D1 (de) Analgetisches antitumorpeptid aus skorpionen und verfahren zu dessen herstellung
DE602004025132D1 (de) Asymmetrische reduktive aminierung von ketosäurederivaten zur herstellung von aminosäurederivaten
EP1506958A4 (fr) Procede de production de shogaol et produits intermediaires servant a la synthese de shogaol
WO2002083554A3 (fr) Procede de production d'acide de salpetre extremement pur
WO2005023791A3 (fr) Procede de production de mycophenolate mofetil
MXPA05007315A (es) Sintesis de (r) y (s)-aminocarnitina y derivados de esta de acido d- y l-aspartico.
EP1142859A3 (fr) Procédé de préparation de 3,7-diméthyl-6-octénol optiquement actif et procédé de préparation un intermédiaire pour ce procédé
TWI262913B (en) Manufacturing method of diene compound
ES2333110T3 (es) Beta-aminoalcoholes sustituidos como medicamentos.
WO2003042183A1 (fr) Procede de production de composes pyrazole
MXPA06000995A (es) Amidas novedosas de acido indolil-3-glioxilico sustituidas en el atomo de n, uso de las mismas como medicamento y metodo para la produccion de las mismas.